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Vitamin D may have anti–skin cancer effects, but population-based evidence is lacking. We therefore assessed
associations between vitamin D status and skin cancer risk in an Australian subtropical community. We analyzed
prospective skin cancer incidence for 11 years following baseline assessment of serum 25(OH)-vitamin D in 1,191
adults (average age 54 years) and used multivariable logistic regression analysis to adjust risk estimates for
age, sex, detailed assessments of usual time spent outdoors, phenotypic characteristics, and other possible
confounders. Participants with serum 25(OH)-vitamin D concentrations above 75 nmol l 1 versus those below
75 nmol l 1 more often developed basal cell carcinoma (odds ratio (OR)¼ 1.51 (95% confidence interval (CI):
1.10–2.07, P¼ 0.01) and melanoma (OR¼ 2.71 (95% CI: 0.98–7.48, P¼ 0.05)). Squamous cell carcinoma incidence
tended to be lower in persons with serum 25(OH)-vitamin D concentrations above 75 nmol l 1 compared with
those below 75 nmol l 1 (OR¼ 0.67 (95% CI: 0.44–1.03, P¼ 0.07)). Vitamin D status was not associated with skin
cancer incidence when participants were classified as above or below 50 nmol l 1 25(OH)-vitamin D. Our findings
do not indicate that the carcinogenicity of high sun exposure can be counteracted by high vitamin D status. High
sun exposure is to be avoided as a means to achieve high vitamin D status.
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INTRODUCTION
Vitamin D may have anticancer properties (World Health
Organization International Agency for Research on Cancer,
2008), but evidence for its possible effect on skin cancer risk is
limited. A substantial body of evidence from experimental
studies shows that vitamin D may protect the skin against
ultraviolet radiation–induced DNA damage and may prevent
keratinocyte skin cancers (Bikle, 2008; Dixon et al., 2011).
Vitamin D also inhibits growth in melanoma cell lines
(Szyszka et al., 2012). Thus, population-based evidence for a
possible anti–skin cancer effect of vitamin D is needed. Sun
exposure, which initiates cutaneous vitamin D production, is
the main environmental risk factor for the development of skin
cancer. Thus, the risks and possible benefits of sun exposure
need to be considered carefully given the large burden of skin
cancer in many white populations. It has been suggested that
current clinical criteria for vitamin D sufficiency are too low
to achieve anticancer and other disease-prevention benefits.
In 2011, the United States Institute of Medicine concluded
that practically everyone has sufficient serum 25(OH)-vitamin
D levels when sufficiency is defined as levels of at least
50 nmol l1 (20 ng ml 1) (IOM, 2011). However, the
optimal serum level of 25(OH)-vitamin D is currently the
subject of intense debate, and a higher level of 75 nmol per l
25(OH)-vitamin D (30 ng ml1) has been proposed (Bischoff-
Ferrari et al., 2006; Vieth et al., 2007) and adopted by many
(Binkley et al., 2012; Friedman et al., 2012). To assess the
association between these target levels and skin cancer risk,
we carried out a prospective study in a subtropical Australian
community.
RESULTS
In the 11-year follow-up period, 300 (25%) participants
developed basal cell carcinoma (BCC), 176 (15%) developed
squamous cell carcinoma (SCC), and 17 (1%) participants
were diagnosed with melanoma. Persons affected by BCC or
SCC were older, more likely to be male and to have fair skin,
more prone to sunburn, more likely to have severe elastosis of
the neck, freckling on the back, and a history skin cancer,
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whereas melanoma was associated with elastosis (Table 1). Of
1,191 participants aged 54 years on average (range 29–79),
266 (22%) had serum 25(OH)-vitamin D concentrations
below 50 nmol l1, 562 (47%) had concentrations between
50 and 75 nmol l 1, and 363 (31%) had concentrations above
75 nmol l1. Participants with serum 25(OH)-vitamin D con-
centrations above 75nmol l 1 versus those below 75nmol l 1
more often developed BCC (odds ratio (OR)¼1.51 (95%
confidence interval (CI): 1.10–2.07, P¼0.01) and melanoma
(OR¼2.71 (95% CI: 0.98–7.48, P¼0.05)) during follow-up
after allowing for all variables that caused confounding in a
multivariable model, as well as usual time spent outdoors
(Table 2). SCC incidence was lower in persons with serum
25(OH)-vitamin D concentrations above 75 nmol l1 com-
pared with those below 75 nmol l1 (OR¼ 0.67 (95% CI:
0.44–1.03, P¼0.07)).
When serum 25(OH)-vitamin D was considered a contin-
uous variable, risk of BCC (P¼ 0.10) and melanoma (P¼0.10)
tended to be higher in persons with higher serum 25(OH)-
vitamin D concentrations and lower for SCC (P¼0.12). For
BCC, the OR was 1.35 (95% CI: 0.94–1.93), for SCC it was
0.68 (0.42, 1.11), and for melanoma it was 2.70 (95% CI:
0.83–8.77) for every 50 nmol l1 increase in 25(OH)-vitamin
D concentration.
When we separately compared participants with vitamin D
concentrations between 50 and 75 nmol l1 (n¼562) and
those with concentrations above 75 nmol l 1 (n¼362) with
persons with concentrations below 50 nmol l1 (n¼ 266),
those with concentrations above 75 nmol l1 had an
increased risk of BCC (OR¼ 1.74 (95% CI: 1.13–2.67)
compared with persons in the reference group. The same
comparisons were less precise for melanoma because of small
Table 1. Characteristics by skin cancer status of 1,191 participants of the Nambour skin cancer study
Basal cell carcinoma Squamous cell carcinoma Melanoma
Yes (n¼ 300) No (n¼ 891) P-value1 Yes (n¼176) No (n¼1,014) P-value1 Yes (n¼ 17) No (n¼1,174) P-value1
Sex
Male 151 (50%) 385 (43%) 0.032 99 (56%) 437 (43%) 0.001 5 (29%) 531 (45%) 0.193
Female 149 (50%) 506 (57%) 77 (44%) 578 (57%) 12 (71%) 643 (55%)
Age
Age (mean) in 1996 58 years 52 years o0.0001 63 years 52 years o0.0001 58 years 54 years 0.174
Skin color
Fair 185 (62%) 483 (54%) 0.014 116 (66%) 552 (54%) 0.002 11 (64%) 657 (56%) 0.856
Medium 102 (34%) 344 (39%) 55 (31%) 391 (39%) 3 (18%) 443 (38%)
Olive 13 (4%) 63 (7%) 5 (3%) 71 (7%) 3 (18%) 73 (6%)
Propensity to burn/tan after acute sun exposure
Always burn 76 (25%) 176 (20%) 0.013 68 (39%) 184 (18%) o0.0001 6 (35%) 246 (21%) 0.166
Burn then tan 202 (68%) 617 (69%) 96 (55%) 723 (71%) 10 (59%) 809 (69%)
Tan only 22 (7%) 97 (11%) 12 (7%) 107 (11%) 1 (6%) 118 (10%)
Elastosis of neck
None 18 (6%) 172 (19%) o0.0001 2 (1%) 188 (18%) o0.0001 1 (6%) 189 (16%) 0.010
Mild/moderate 154 (51%) 510 (57%) 75 (43%) 589 (58%) 6 (35%) 658 (56%)
Severe 128 (43%) 209 (24%) 99 (56%) 238 (24%) 10 (59%) 327 (28%)
Freckling of back
None 41 (13%) 184 (21%) o0.0001 22 (12%) 203 (20%) o0.0001 1 (6%) 224 (19%) 0.323
Mild 118 (40%) 395 (44%) 67 (38%) 446 (44%) 9 (53%) 504 (43%)
Moderate 89 (30%) 219 (25%) 51 (29%) 257 (25%) 4 (23%) 304 (26%)
Severe 51 (17%) 93 (10%) 36 (21%) 108 (11%) 3 (18%) 141 (12%)
Nevi on back
None 39 (13%) 102 (12%) 0.0043 35 (20%) 106 (11%) o0.0001 1 (6%) 140 (12%) 0.529
1–10 218 (73%) 582 (65%) 128 (73%) 672 (66%) 12 (71%) 788 (67%)
X11 42 (14%) 207 (23%) 13 (7%) 236 (23%) 4 (23%) 245 (21%)
History of skin cancer
No 118 (39%) 676 (76%) o0.0001 52 (30%) 742 (73%) o0.0001 8 (47%) 786 (67%) 0.084
Yes 182 (61%) 215 (24%) 124 (70%) 273 (27%) 9 (53%) 388 (33%)
1P-value from Mantel–Haenzel w2-test (categorical data) or analysis of variance (continuous data).
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numbers resulting in wide CIs (OR¼ 2.75 (95% CI: 0.68–
11.17)), whereas for SCC they were of borderline statistical
significance (OR¼0.61, 95% CI: 0.35–1.06). Persons
with 25(OH)-vitamin D concentrations between 50 and
75 nmol l1 did not have an increased risk of BCC or
melanoma or decreased risk of SCC compared with those in
the below 50 nmol l1 category (estimates not shown).
Vitamin D status was not associated with skin cancer
incidence when participants were classified as above or below
50 nmol per l 25(OH)-vitamin D (Supplementary Table
online).
Few participants (13%) used vitamin D supplements and
associations remained when analyses were restricted to non-
supplement users (results not shown). Vitamin D status was
not associated with skin cancer incidence when analyses were
restricted to persons who had no history of skin cancer before
the start of the study (results not shown).
Allocation to sunscreen and beta-carotene treatment groups
during the trial was not associated with vitamin D status
(data not shown). Vitamin D status was closely associated
with indicators of UV exposure. Longer time spent outdoors
in the 6 months preceding venipuncture was associated with
higher mean 25(OH)-vitamin D concentrations (hardly ever:
59.4 nmol l1, o50% of the time: 66.4 nmol l1, 450% of
the time: 76.1 nmol l 1, Po0.0001) and was highly correlated
with time spent outdoors during follow-up (weighted average
of the same data ascertained twice yearly (1997–2002) and
yearly (2003–2007), r¼ 0.73, Po0.0001). Participants with
continued high sun exposure during follow-up had higher
25(OH)-vitamin D concentrations at baseline (73.5 vs.
62.8 nmol l1, Po0.0001).
DISCUSSION
Previous observational studies of vitamin D status and
skin cancer have shown mixed results. Unlike our study, they
mostly have not included participants who represent the
general population risk (Asgari et al., 2010; Tang et al.,
2010; Eide et al., 2011), nor have they been able to fully
account for long-term sunlight exposure and other risk factors
(Liang et al., 2012; Major et al., 2012). A randomized trial
(Tang et al., 2011) of women who took a vitamin D and
calcium supplement compared with those who took placebo
reported reduced incidence of melanoma in women with a
history of non-melanoma skin cancer. As the independent
effects of vitamin D and calcium could not be ascertained
from this trial, and because the association was only seen in a
subgroup of women, it is difficult to relate their results to vitamin
D effects in the general population.
It is unclear why serum vitamin levels were positively
associated with risk of basal cell carcinoma and
melanoma, but tended to be negatively associated with SCC
incidence. Our data on recent sun exposure relied on self-
reports, but any misclassification is unlikely to have differen-
tially affected the three skin cancer types. Melanoma and BCC
share several risk factors (Richmond-Sinclair et al., 2012) not
seen for SCC, and have a longer latency period. However,
SCC tends to show a clearer dose–response relationship
with sun exposure history than BCC or melanoma (van der
Pols, 2010), and some experimental evidence suggests
prevention of SCC through nongenomic responses to vitamin
D (Dixon et al., 2011).
Our results show that in particular serum 25(OH)-vitamin D
concentrations above 75nmol l 1 are associated with increased
risk of BCC and that concentrations between 50 and
75 nmol l1 are probably not associated with such increased
risk. These findings add to the current debate about optimal
vitamin D status indicators, and indicate that in a group of
normal, community-based adults, serum 25(OH)-vitamin D
concentrations above 75 nmol l1 is associated with an
increased probability of morbidity due to skin cancer. Further,
our results indicate that this is particularly the case for persons
with a past history of skin cancer.
Only one vitamin D serum measure was available, but this
was closely correlated with concurrent and subsequent sun
exposure, and thus is likely to be indicative of long-term
status. Despite the long follow-up period, the number of
melanomas included in our analyses was small, and this has
limited the number of subgroup comparisons that were possi-
ble. We have previously shown that regular sunscreen reduces
the risk of SCC (Green et al., 1999; van der Pols et al., 2006)
and melanoma (Green et al., 2011), but overall sunscreen use
in the 8 months preceding venipuncture was not associated
with vitamin D status in our study population (Jayaratne et al.,
Table 2. Associations between serum 25(OH)-vitamin D
concentration and skin cancer risk
Serum 25(OH)-vitamin D concentration
o75nmol l1 X75nmol l1 P-value
Basal cell carcinoma
n/N (%) 193/828 (23%) 107/363 (29%)
OR1 basic model 1.00 1.38 (1.04, 1.82) 0.02
OR age and sex 1.00 1.47 (1.10, 1.97) 0.01
OR2 multivariable 1.00 1.51 (1.10, 2.07) 0.01
Squamous cell carcinoma
n/N (%) 132/828 (16%) 44/363 (12%)
OR basic model 1.00 0.73 (0.50, 1.15) 0.09
OR age and sex 1.00 0.74 (0.50, 1.10) 0.14
OR2 multivariable 1.00 0.67 (0.44, 1.03) 0.07
Melanoma
n/N (%) 9/828 (1%) 8/363 (2%)
OR basic model 1.00 2.05 (0.79, 5.36) 0.14
OR age and sex 1.00 2.71 (1.00, 7.31) 0.05
OR2 multivariable 1.00 2.71 (0.98, 7.48) 0.05
Abbreviation: OR, odds ratio.
1OR and 95% confidence interval from logistic regression analysis.
2Adjusted for age, sex, b-carotene, and sunscreen allocations during the
trial, personal history of skin cancer before 1996, family history of skin
cancer, elastosis neck (BCC and SCC only), freckling back (BCC and SCC
only), skin color, propensity to burn (BCC and SCC only), usual time spent
outdoors.
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2012). It is appears that the UV radiation that reaches a
person’s skin after sunscreen application is adequate
for vitamin D production, but that UV is blocked suffi-
ciently to prevent skin cancer and actinic keratosis (Marks
et al., 1995).
Despite the long follow-up period, the number of melano-
mas included in our analyses was small, and this has limited
the stability of the estimates and the number of subgroup
comparisons that were possible. We could not explore the
effects of vitamin D early in life on skin cancer risk in this
adult cohort, nor can we rule out the presence of some
residual confounding of the results by recent sun exposure,
although the latter seems unlikely given the associations with
two cancers with long latency periods.
In conclusion, our findings do not indicate that the carcino-
genicity of high sun exposure can be counteracted by high
vitamin D status. High sun exposure is to be avoided as a
means to achieve high vitamin D status.
MATERIALS AND METHODS
We analyzed prospective skin cancer incidence for 11 years
following serum 25(OH)-vitamin D assessment in adults who had
participated in a skin cancer prevention trial (1992–1996) of daily
sunscreen use and beta-carotene supplementation (Green et al.,
1999). Skin phenotype and photoaging were assessed and detailed
sun exposure and sun protection histories were obtained. In August
1996, when the intervention ceased, all trial participants were
asked to enroll in a follow-up study of skin cancer. During follow-
up until the end of 2007, all incident skin cancers were monitored
through an extensive surveillance system, which included regular
questionnaires, a complete skin examination in 2000, and reporting
by pathology laboratories. This methodology ensured virtually
100% ascertainment of histologically confirmed skin cancers
(Valery et al., 2004). Blood was drawn from 1,191 participants
(73% of 1,621 persons enrolled in the trial) in August 1996 (end of
winter; average UV index moderate to high (Australian Radiation
Protection and Nuclear Safety Agency, 2012), and concentrations
of serum 25(OH)-vitamin D were measured by Liaison 25(OH)D
Assay (Ersfeld et al., 2004). Twelve random samples were measured
in duplicate, showing high intra-assay correlation (Pearson’s
r¼ 0.83), and 29 random samples were compared with HPLC
analysis (Pearson’s r¼ 0.79). Serum concentrations were
dichotomized and ORs obtained from logistic regression analysis.
Multivariable models included age, sex, and trial treatment
allocations (daily vs. discretionary sunscreen use, daily beta-
carotene supplement vs. placebo). Other factors assessed in detail
as potential confounding factors included skin phenotype,
freckling, nevi, and skin aging (as assessed by a dermatologist);
body mass index (based on measured height and weight); sunburn
history, frequency of sunscreen use, occupational sun exposure,
time spent outdoors on weekdays and weekends in the 6 months
preceding venipuncture; physical activity level; the presence of a
medical condition; personal and family history of skin cancer;
calcium and vitamin D intake (Bonthuis et al., 2010); and smoking
status (assessed by questionnaire). Ethical approval was obtained
from the institutional ethics committee. All participants provided
informed written consent, and the study adhered to the Declaration
of Helsinki principles.
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